Suleshvari Pharma Pvt. Ltd. has strategically acquired the IPCA Ankleshwar manufacturing plant, including plant infrastructure, machinery, workforce, and ongoing business operations.

This acquisition significantly strengthens the company’s manufacturing capabilities and enhances its position in the Active Pharmaceutical Ingredients (API) and intermediates segment — enabling accelerated scale-up without the time and cost of greenfield development.